Blue Owl Capital Holdings LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $303 Million distributed in 141 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $33.7M, Pliant Therapeutics, Inc. with a value of $33.7M, Owl Rock Capital Corp with a value of $27.4M, Larimar Therapeutics, Inc. with a value of $27.3M, and Proshares Ultrapro Qqq with a value of $23.6M.
Examining the 13F form we can see an increase of $62.5M in the current position value, from $241M to 303M.
Blue Owl Capital Holdings LP is based out at New York, NY
Below you can find more details about Blue Owl Capital Holdings LP portfolio as well as his latest detailed transactions.